dr. hamilton on prognostic impact of molecular mutations in aml and mds on hct outcomes
Published 8 years ago • 98 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
0:56
dr. betty hamilton on molecular mutations in aml and mds
-
2:03
prognostic significance of molecular mrd in npm1-mutated aml treated with venetoclax-based therapy
-
2:59
the prognostic and therapeutic implications of mrd in aml
-
7:19
prognostic significance of mrd in aml
-
2:55
prognostic drivers in aml and mds
-
3:03
prognostic impact of flt3-itd in older patients with aml
-
3:18
the impact of secondary aml mutations on the prognosis of patients with npm1-mutated aml
-
2:26
impact of allelic state on os in tp53-mutant aml and hr-mds
-
34:15
from mds to aml: what every patient needs to know 11/28/17
-
1:13
molecular mrd as a prognostic marker for aml patients with mutated cebpa
-
3:07
the impact of blast enumeration & co-occurring myelodysplasia-related mutations in npm1-mutated aml
-
2:17
oncogenic mutational networks in acute myeloid leukemia (aml) and myelodysplastic syndromes (mds)
-
3:23
the prognostic impact of pre-transplant mrd-positivity in patients with aml
-
4:28
the rationale of flt3 inhibition in aml
-
1:38
value of mrd in patients with npm1-mutated aml
-
2:27
dr eckfeldt on the implications of improved mrd testing in aml
-
3:08
rationale for targeting kit in asm
-
1:49
the prognostic value of flt3-itd residual disease in aml
-
1:37
what is acute myeloid leukemia with myelodysplasia-related changes (aml-mrc)?